Ashwagandha under the microscope: 12-Month safety check begins
NCT ID NCT06244147
First seen Nov 06, 2025 · Last updated May 12, 2026 · Updated 28 times
Summary
This study followed 200 adults aged 18 to 65 who were already prescribed KSM-66 ashwagandha by their doctor. Over 12 months, researchers tracked side effects and lab results to see if long-term use is safe. The goal was to gather safety data, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SF Research Institute
San Francisco, California, 94127, United States
Conditions
Explore the condition pages connected to this study.